会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明申请
    • NOVEL SUBSTITUTED INDAZOLES, THE PREPARATION THEREOF, AND USE OF SAME IN THERAPEUTICS
    • 新型替代治疗剂,其制剂及其在治疗中的应用
    • WO2009010660A2
    • 2009-01-22
    • PCT/FR2008000843
    • 2008-06-18
    • SANOFI AVENTISALETRU MICHELDAMOUR DOMINIQUEMONSEAU CATHERINEMOUGENOT PATRICKNAMANE CLAUDIENARDI FREDERICONEMECEK PATRICKPHILIPPO CHRISTOPHE
    • ALETRU MICHELDAMOUR DOMINIQUEMONSEAU CATHERINEMOUGENOT PATRICKNAMANE CLAUDIENARDI FREDERICONEMECEK PATRICKPHILIPPO CHRISTOPHE
    • C07D401/12A61K31/454A61K31/4545A61P35/00C07D211/08C07D213/06C07D231/56C07D233/70C07D235/06C07D401/14
    • C07D401/14C07D401/12
    • The invention relates to compounds of formula (I) wherein: E is a grouping (i) of formula -NT-CO-O- or -NT-CX-NT'- wherein X is =O or =S and T and T', that can be identical or different and selected independently, from H or an alkyl group, or (ii) forming a five-membered or six-membered ring bound in position 5 or 6 of the indazole nucleus by -NT- or by the nitrogen atom N1; R1 is at least one substituent selected independently when there are several, and being a halogen atom, an alkyl, alkenyl, alkynyl, halogenoalkyl, halogenoalcoxy, aryl, heteroaryl, heterocycloalkyl, cycloalkyl, CN, NRR', OR, NO2, COOR, CONRR', or NRCOR' group; R2 is a hydrogen atom, or an alkyl, alkenyl or alkynyl group; R3 is at least one substituent selected independently when there are several, and being a hydrogen atom, an alkyl, alkenyl, alkynyl, halogenoalcoxy, aryl, heteroaryl, cycloalkyl, heterocycloalkyl, CN, NRR', CF3, OR, NO2, COOR, CONRR', or NRCOR' group; R4 is a hydrogen atom or a halogen atom, an alkyl, alkenyl, alkynyl, aryl, heteroaryl, heterocycloalkyl, -NR-CO-R', COOR, NRR', CHO, or CONR(OR') group; R and R' are identical or different and are independently a hydrogen atom, or an alkyl, aryl, heterocycloalkyl, cycloalkyl or heteroaryl group; and n1 is a whole number between 0 and 5, and n3 is a whole number between 0 and 3.
    • 本发明涉及式(I)化合物,其中:E为式-NT-CO-O-或-NT-CX-NT'-的分组(i),其中X为= O或= S且T和T' ,可以相同或不同,独立地选自H或烷基,或(ii)通过-NT-形成在吲唑核的5或6位上结合的五元或六元环,或通过氮 原子N1 当有几个并且是卤素原子时,R1是至少一个取代基,其中烷基,烯基,炔基,卤代烷基,卤代烷氧基,芳基,杂芳基,杂环烷基,环烷基,CN,NRR',OR,NO2,COOR,CONRR '或NRCOR'组; R2是氢原子,或烷基,烯基或炔基; 当存在数个并且为氢原子的烷基,烯基,炔基,卤代烷氧基,芳基,杂芳基,环烷基,杂环烷基,CN,NRR',CF 3,OR,NO 2,COOR,CONRR时,R 3是至少一个独立选择的取代基 '或NRCOR'组; R4是氢原子或卤原子,烷基,烯基,炔基,芳基,杂芳基,杂环烷基,-NR-CO-R',COOR,NRR',CHO或CONR(OR')基团; R和R'相同或不同,独立地为氢原子,或烷基,芳基,杂环烷基,环烷基或杂芳基; n1为0〜5之间的整数,n3为0〜3的整数。